Drug Discovery World

OCTOBER 17, 2023

Andreas Dreps DDW is delighted to confirm that ICON’s SrVP and Global Head of Science Andreas Dreps and Senior Director Muaiad Kittaneh will present a session on identifying research strategies to get to market faster. The post DDW Cancer Research Summit: Strategies to get to market faster appeared first on Drug Discovery World (DDW).

Marketing 130

Marketing Research Clinical Trials Science 130

Fierce BioTech

SEPTEMBER 5, 2024

Overcoming drug development hurdles with phase-appropriate technology transfers Discover how phase-appropriate technology transfers can help you overcome regulatory challenges, reduce costs, and accelerate your path to commercialization. Learn strategies to maximize efficiency and focus on what you do best—innovating new therapies.

Drug Development 52

Drug Development Drugs Therapies Marketing 52

Drug Discovery World

AUGUST 30, 2022

The Phacilitate Advanced Therapies Europe 2022 conference will take place from 30 August to 1 September at the Royal Lancaster in London, UK. The conference is the European twin to Phacilitate Advanced Therapies Week, an event held in January in Florida, US. Creating a sustainable cell & gene therapy company.

Therapies 246

Therapies Hospitals Clinical Trials Clinical Development 246

Drug Discovery World

JANUARY 25, 2023

Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. autologous therapies/solid tumours/ indications outside of oncology?) Register for free now.

Therapies 130

Therapies Drug Development Marketing Disease 130

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies.

Therapies 162

Therapies Clinical Trials FDA Approval Virus 162

Drug Discovery World

DECEMBER 8, 2023

Andrew Busey , Co-Founder, Form Bio discusses why vertical AI is set to reshape the cell and gene therapy sector. The cell and gene therapy industry is no exception to this digital transformation. It is imperative for the industry to communicate the precise composition and attributes of these therapies to regulatory bodies.

Therapies 162

Therapies Clinical Trials Small Molecule Production 162

Drug Discovery World

AUGUST 4, 2023

Dr Christian K Schneider , Head of Biopharma Excellence at PharmaLex, presents the findings of an industry panel debate on barriers to commercialisation of novel treatments, and the most effective strategies to bring them to market. Other challenges involve talent gaps, particularly now that cell and gene therapy manufacturing is maturing.

Therapies 130

Therapies Pharma Companies Marketing Treatment 130

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. New therapeutics of course depend on an understanding of biological mechanisms.

Drug Development 246

Drug Development Clinical Trials Drugs Virus 246

Drug Discovery World

OCTOBER 31, 2023

Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. Currently, 15 trials of the new potential therapies for ALS have included NfL as an endpoint 8.

Drug Development 147

Drug Development Disease Drugs Clinical Trials 147

Alta Sciences

AUGUST 29, 2024

Engaging at the outset with a fully integrated and experienced drug development partner can ensure safety, with timely data sharing at every step of the drug development plan, and facilitate agile, flexible decision-making and planning. billion USD in 2023 to $166.53 billion USD by 2028.

Drug Development 52

Drug Development Small Molecule Clinical Trials Drugs 52

Drug Target Review

JULY 18, 2024

Why is detecting cancers via liquid biopsy before they become visible on imaging important for drug development, not just diagnostics? We believe liquid biopsy is very helpful for oncology drug development because the reduction and clearance of circulating DNA occurs quickly before radiographic imaging is available.

Drug Development 59

Drug Development Clinical Trials Drugs Small Molecule 59

Drug Discovery World

SEPTEMBER 6, 2022

In recent years the advanced therapy industry has been the most significant disruptor in medicine. Cell and gene therapies are not only transforming the way diseases are treated but are also aiming to cure entirely new patient populations. Record breaking investments in 2021 fuel an industry on fire . billion raised.

Therapies 130

Therapies Clinical Trials Production Disease 130

Drug Target Review

AUGUST 7, 2024

The pharmaceutical industry is undergoing a major shift towards the development of breakthrough medicines and advanced therapies. This continued innovation highlights the complexity of the drug development process, particularly as the field is highly regulated by health authorities around the world.

Drug Development 59

Drug Development Clinical Pharmacology Clinical Trials Packaging 59

Drug Discovery World

FEBRUARY 7, 2023

Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies’, brought you by Corning. Given the potential of emerging advanced therapies, market demand is likely to continue to grow.

Therapies 130

Therapies Marketing Drugs Research 130

Drug Discovery World

FEBRUARY 14, 2023

The combination of our generative AI platform and SJCI’s large biorepositories and related molecular analysis database can accelerate the development of better biologics for patients, faster.” Through the partnership, Absci will integrate SJCI’s annotated molecular data assets into its target discovery platform.

Therapies 130

Therapies Clinical Trials Trials Drug Development 130

PPD

SEPTEMBER 25, 2023

As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. The adoption of new innovations, strategies and technologies offers opportunities to address persistent challenges and develop suitable approaches for the future.

Drug Development 104

Drug Development Clinical Trials Drugs Trials 104

Drug Discovery World

DECEMBER 21, 2023

DDW’s top 10 most popular articles for 2023 reflect the key subjects in drug discovery and development. In a record year for gene therapy approvals, it isn’t surprising that cell & gene therapy (CGT) has been a hot topic. DDW Multimedia Editor Megan Thomas explored three trends in the market.

FDA Approval 147

FDA Approval Therapies Small Molecule Clinical Trials 147

Drug Discovery World

SEPTEMBER 6, 2022

Tony Khoury, Executive Vice President of Project Farma and Anshul Mangal , President & General Counsel of Project Farma, share how the industry is leveraging stronger education programmes to close the advanced therapy talent gap. . The need for solutions to the industry’s biggest bottlenecks are growing daily. .

Therapies 130

Therapies Clinical Trials Government Production 130

Drug Discovery World

FEBRUARY 7, 2023

Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more challenging when the cells of interest are attachment-dependent, such as induced pluripotent stem cells (iPSCs).

Therapies 130

Therapies Marketing Drugs Research 130

PPD

SEPTEMBER 27, 2023

The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. Applying artificial intelligence (AI) to drug development (e.g., mRNA, drug discovery platforms) ranked as the No.

Drug Development 52

Drug Development Clinical Trials Clinical Research Drugs 52

Drug Discovery World

JANUARY 30, 2023

Register to attend Cell and gene therapy: sustaining growth and maximising opportunities, a free-to-attend DDW webinar, supported by Benchling and BPS Bioscience, on February 17, 2023 at 8am PST / 11am EST / 4pm GMT / 5pm CET. Cell and gene therapies (CGT) are transforming the way diseases are treated.

Disease 130

Disease Treatment Therapies Drug Development 130

Drug Discovery World

FEBRUARY 6, 2023

On February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET, join DDW to enjoy this free webinar, Cell and gene therapy: sustaining growth and maximising opportunities. Cell and gene therapies (CGT) are transforming the way diseases are treated.

Therapies 130

Therapies Drug Development Marketing Disease 130

Drug Discovery World

JANUARY 25, 2023

Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future.

Therapies 130

Therapies Drug Development Marketing Disease 130

Drug Target Review

JUNE 19, 2024

The mission of Lineage Cell Therapeutics is to deliver on some of the early promises of cell therapy. Cell therapy as a concept is a wonderful idea, but many of the early efforts never generated the kind of clinical data that gets people excited and leads to new medicines. In some cases, cell therapy can be curative for the patient.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

Drug Discovery World

FEBRUARY 13, 2024

Often this can be drug approvals, exciting research into hard-to-treat indications, or even regulatory updates that enable players within the sector to utilise the latest technologies and drive therapies to market faster, ultimately benefitting patients. Progress isn’t stagnant though.

Small Molecule 147

Small Molecule Drugs Therapies Pharmaceutical Companies 147

Drug Discovery World

JULY 20, 2023

This is the latest episode of the free DDW narrated podcast, “A business case for drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. In the first article, Drug Discovery World Editor Reece Armstrong looks at how a number of deals in pharma have sparked excitement in the industry.

Drug Development 100

Drug Development Drugs Therapies Science 100

Drug Discovery World

AUGUST 1, 2024

They are called: Optimising AAV capsid purification through improved analytics How transcriptomics is driving drug discovery Scandinavia: Insight into opportunities for drug discovery In the first article, Svea Cheeseman from Refeyn explains why better efficiency is needed to advance the production of viral vectors for use in gene therapies.

Drugs 130

Drugs Therapies Marketing Production 130

Drug Discovery World

SEPTEMBER 26, 2023

Offering precision and flexibility, the tools offered by synthetic biology place it in a competitive position as it helps drug developers cut development time as well as costs. Download this In Focus eReport to gain a full understanding of the current market for synthetic biology and its promise to treat disease in a new way.

Vaccine 130

Vaccine Drug Development Science Marketing 130

PPD

DECEMBER 19, 2022

PPD, Thermo Fisher Scientific ’s clinical research business, surveyed more than 150 decision-making leaders at pharmaceutical and biotech companies around the globe to collect key insights on the state of the evolving drug development industry. The opportunity to leverage new technologies in drug development (e.g.,

Clinical Trials 52

Clinical Trials Drug Development Trials Clinical Research 52

Drug Discovery World

NOVEMBER 3, 2023

News round-up for 30 October – 3 November by DDW Editor Reece Armstrong My news highlights this week feature a variety of exciting clinical trial results and launches that are examining therapies for much-needed disease areas, new drug approvals and even a space mission with a pharma twist.

Clinical Trials 130

Clinical Trials Drugs Trials Therapies 130

Drug Discovery World

FEBRUARY 12, 2024

“In the upcoming year, we will see the expansion of new, more complex markets and updated requirements from regulators. Without fixing the current, broken PV models, the continuous cycle of more complexity in the market, which then pushes organisations to incorporate automation into insufficient processes, will massively hinder PV operations.

Small Molecule 349

Small Molecule Regulations Clinical Trials Therapies 349

Drug Discovery World

OCTOBER 16, 2023

A company within this ecosystem is STORM Therapeutics, a clinical stage biotechnology company creating novel small molecule therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. billion in funding. Northern Ireland “Northern Ireland is a medtech super-hub,” says Saleko.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Drug Discovery World

JANUARY 9, 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. The therapy has shown positive results in Phase III trials in both breast and lung cancer.

Drugs 173

Drugs Therapies Treatment Virus 173

Drug Discovery World

JULY 20, 2023

This is the latest episode of the free DDW narrated podcast, “A business case for drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. In the first article, Drug Discovery World Editor Reece Armstrong looks at how a number of deals in pharma have sparked excitement in the industry.

Drugs 100

Drugs Drug Development Therapies Science 100

Drug Discovery World

AUGUST 18, 2023

Thermo Fisher Scientific has completed its acquisition of CorEvitas, a provider of real-world evidence for approved medical treatments and therapies, for $912.5 CorEvitas will become part of Thermo Fisher’s Laboratory Products and Biopharma Services segment. The transaction is expected to be slightly accretive in 2023 and deliver $0.03

Laboratories 130

Laboratories Clinical Research Therapies Regulations 130

Drug Discovery World

MAY 6, 2024

During the period 2016-2021, the Brazilian, Chinese and Indian markets grew by 11.7%, 6.7% respectively compared to an average market growth of 5.8% for the top five European Union markets and 5.6% for the US market 2. Even before this, however, Amsterdam was established as an important centre for drug development.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

PPD

AUGUST 28, 2024

For pharmaceutical innovators and drug developers working to bring oncology therapies to market, patients are the “why” behind it all. For many patients, involvement in oncology clinical trials represents a last hope for an effective therapy.

Trials 52

Trials Clinical Trials Therapies Drug Development 52